A detailed history of Black Rock Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,425,031 shares of CDNA stock, worth $79.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,425,031
Previous 5,543,666 2.14%
Holding current value
$79.3 Million
Previous $66.5 Million 13.64%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$7.96 - $12.37 $944,334 - $1.47 Million
-118,635 Reduced 2.14%
5,425,031 $57.5 Million
Q4 2023

Feb 13, 2024

BUY
$4.9 - $12.86 $807,662 - $2.12 Million
164,829 Added 3.06%
5,543,666 $66.5 Million
Q3 2023

Nov 13, 2023

SELL
$7.0 - $11.26 $424,725 - $683,200
-60,675 Reduced 1.12%
5,378,837 $37.7 Million
Q2 2023

Aug 11, 2023

BUY
$7.61 - $9.46 $8.18 Million - $10.2 Million
1,074,531 Added 24.62%
5,439,512 $46.2 Million
Q1 2023

May 12, 2023

SELL
$8.83 - $17.61 $79,717 - $158,983
-9,028 Reduced 0.21%
4,364,981 $39.9 Million
Q4 2022

Feb 13, 2023

BUY
$10.88 - $20.05 $3.94 Million - $7.26 Million
362,341 Added 9.03%
4,374,009 $49.9 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $1.12 Million - $1.84 Million
69,679 Added 1.77%
4,011,668 $68.3 Million
Q2 2022

Aug 12, 2022

BUY
$20.49 - $39.72 $1.52 Million - $2.95 Million
74,293 Added 1.92%
3,941,989 $84.7 Million
Q1 2022

May 12, 2022

SELL
$28.19 - $46.6 $977,234 - $1.62 Million
-34,666 Reduced 0.89%
3,867,696 $143 Million
Q4 2021

Feb 10, 2022

SELL
$41.2 - $73.6 $5.86 Million - $10.5 Million
-142,326 Reduced 3.52%
3,902,362 $177 Million
Q3 2021

Nov 09, 2021

SELL
$59.15 - $91.99 $10.8 Million - $16.8 Million
-182,658 Reduced 4.32%
4,044,688 $256 Million
Q2 2021

Aug 11, 2021

BUY
$63.02 - $95.11 $266 Million - $402 Million
4,227,346 New
4,227,346 $387 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $781M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.